New test set to target growth hormone misuse:
This article was originally published in Clinica
Researchers have developed an immunoassay that could indicate whether an athlete has misused recombinant human growth hormone (r-hGH). "Doping" has until now been considered undetectable because once injected, r-hGH is identical to a form of naturally occurring pituitary-derived human growth hormone, said the research team, which was led by Dr Christian Strasburger of Innenstadt University Hospital, Munich, Germany. In an assessment of 165 serum samples, the test correctly ruled out everyone who had not used r-hGH, according to a letter published in The Lancet (March 13).
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.